Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Autor: Pageaux, G. (Georges-Philippe), Nzinga, C. (Clovis Lusivika), Ganne, N. (Nathalie), Samuel, D. (Didier), Dorival, C. (Céline), Zoulim, F. (Fabien), Cagnot, C. (Carole), Decaens, T. (Thomas), Thabut, D. (Dominique), Asselah, T. (Tarik), Mathurin, P. (Philippe), Habersetzer, F. (Francois), Bronowicki, J. (Jean-Pierre), Guyader, D. (Dominique), Rosa, I. (Isabelle), Leroy, V. (Vincent), Chazouilleres, O. (Olivier), de Ledinghen, V. (Victor), Bourliere, M. (Marc), Causse, X. (Xavier), Cales, P. (Paul), Metivier, S. (Sophie), Loustaud-Ratti, V. (Véronique), Riachi, G. (Ghassan), Alric, L. (Laurent), Gelu-Simeon, M. (Moana), Minello, A. (Anne), Gournay, J. (Jérôme), Geist, C. (Claire), Tran, A. (Albert), Abergel, A. (Armand), Portal, I. (Isabelle), d'Alteroche, L. (Louis), Raffi, F. (François), Fontaine, H. (Hélène), Carrat, F. (Fabrice), Pol, S. (Stanislas), Baumert, Thomas F., Doffoel, M. (Michel), Mutter, C. (Catherine), Simo-Noumbissie, P. (Pauline), Razi, E. (Esma)

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)

Background In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a previous history of decompensated cirrhosis following treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64389812730cdee1f356f6f46786008
https://hal.archives-ouvertes.fr/hal-03555553/document

Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis: a mediation analysis

Autor: Chalouni, M. (Mathieu), Pol, S. (Stanislas), Sogni, P. (Philippe), Fontaine, H. (Helene), Lacombe, K. (Karine), Lacombe, J. (Jean-Marc) M. (M), Esterle, L. (Laure), Dorival, C. (Céline), Bourlière, M. (Marc), Bani-Sadr, F. (Firouzé), de Ledinghen, V. (Victor), Zucman, D. (David), Larrey, D. (Dominique), Salmon, D. (Dominique), Carrat, F. (Fabrice), Wittkop, L. (Linda), Rey, D. (D), Partisani, M., Batard, M.L., Cheneau, C., Priester, M. (M), Bernard-Henry, C., De Mautort, E., Gantner, P. (Pierre), Fafi-Kremer, S. (Samira), Habersetzer, F. (Francois), Baumert, Thomas F., Doffoel, M. (Michel), Mutter, C. (Catherine), Simo-Noumbissie, P. (Pauline), Razi, E. (Esma)

OBJECTIVES: HIV-coinfected patients experience higher incidences of non-liver-related cancers than HCV-monoinfected patients. Chronic inflammation, immunosuppression, but also higher tobacco or alcohol consumption and metabolic dysregulation could ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4060::444afab836c40c275d101f72f81cb3b2

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

Autor: Collette, S., Bonnetain, F. ^*, Paoletti, X., Doffoel, M., Bouché, O., Raoul, J.L., Rougier, P., Masskouri, F., Bedenne, L., Barbare, J.C.

Publikováno v: In Annals of Oncology June 2008 19(6):1117-1126

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

Autor: Oussalah, A. (Abderrahim), Avogbe, P. (Patrice Hodonou), Guyot, E. (Erwan), Chery, C. (Céline), Guéant-Rodriguez, R. (Rosa-Maria), Ganne-Carrié, N. (Nathalie), Cobat, A. (Aurélie), Moradpour, D. (Darius), Nalpas, B. (Bertrand), Negro, F. (Francesco), Poynard, T. (Thierry), Pol, S. (Stanislas), Bochud, P. (Pierre-Yves), Abel, L. (Laurent), Jeulin, H. (Hélène), Schvoerer, E. (Evelyne), Chabi, N. (Nicodème), Amouzou, E. (Emile), Sanni, A. (Ambaliou), Barraud, H. (Hélène), Rouyer, P. (Pierre), Josse, T. (Thomas), Goffinet, L. (Laetitia), Jouve, J. (Jean-Louis), Minello, A. (Anne), Bonithon-Kopp, C. (Claire), Thiefin, G. (Gérard), Di Martino, V. (Vincent), Doffoel, M. (Michel), Richou, C. (Carine), Raab, J. (Jean-Jacques), Hillon, P. (Patrick), Bronowicki, J. (Jean-Pierre), Guéant, J. (Jean-Louis), CiRCE Study Group

The molecular mechanisms of hepatocellular carcinoma (HCC) carcinogenesis are still not fully understood. DNA repair defects may influence HCC risk. The aim of the study was to look for potential genetic variants of DNA repair genes associated with H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4060::543d4740789905e5c7a34a200648c7ac